FARICIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

FARICIMAB

Official Name

English

RG7716

Preferred Name

English

FARICIMAB [JAN]

Common Name

English

RG-7716

Common Name

English

RO6867461

Code

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN ANGIOPOIETIN 2) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-MUS MUSCULUS MONOCLONAL HEAVY CHAIN), DISUL

Systematic Name

English

RO-6867461

Code

English

FARICIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA/LAMBDA WITH DOMAIN CROSSOVER, ANTI-(HOMO SAPIENS-VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF-A, VASCULAR PERMEABILITY FACTOR, VPF)) AND ANTI-(HOMO SAPIENS-ANGIOPOIETIN-2 (ANG-2)), HUMANIZED AND HOMO SAPIENS MONOCLONAL ANTIBODY, BIS

Systematic Name

English

Faricimab [WHO-DD]

Common Name

English

faricimab [INN]

Common Name

English

Y8HA1I28D3

Common Name

English

RG-7716 (ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR/ANTI-ANGIOPOIETIN 2 BISPECIFIC ANTIBODY)

Common Name

English

Code System Code Type Description

SMS_ID

100000178369

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

NCI_THESAURUS

C174885

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

INN

10563

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

WIKIPEDIA

Faricimab

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

DAILYMED

QC4F7FKK7I

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

LEGACY_FDA_UNII

Y8HA1I28D3

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

DRUG BANK

DB15303

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

EVMPD

SUB194079

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

RXCUI

2591519

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

USAN

FG-178

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

CAS

1607793-29-2

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

FDA UNII

QC4F7FKK7I

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

PRIMARY

CAS

2091719-64-9

Created by admin on Tue Apr 01 22:08:24 GMT 2025 , Edited by admin on Tue Apr 01 22:08:24 GMT 2025

NO STRUCTURE GIVEN

ACTIVE MOIETY


					QC4F7FKK7I

FARICIMAB